GCNT4
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4
Also known as: C2GNT3, GCNT4_HUMAN, LINC01336
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P109
- Gene
- GCNT4
- Ensembl
- ENSG00000176928
- Chromosome
- 5
- Canonical length
- 453 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
Predicted to enable acetylglucosaminyltransferase activity. Predicted to be involved in O-glycan processing and carbohydrate metabolic process. Predicted to act upstream of or within several processes, including inter-male aggressive behavior; neutrophil homeostasis; and thyroid hormone metabolic process. Predicted to be located in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
453 residues, UniProt reviewed canonical sequence.
>Q9P109|GCNT4
1 MKIFKCYFKH TLQQKVFILF LTLWLLSLLK LLNVRRLFPQ KDIYLVEYSL STSPFVRNRY
61 THVKDEVRYE VNCSGIYEQE PLEIGKSLEI RRRDIIDLED DDVVAMTSDC DIYQTLRGYA
121 QKLVSKEEKS FPIAYSLVVH KDAIMVERLI HAIYNQHNIY CIHYDRKAPD TFKVAMNNLA
181 KCFSNIFIAS KLEAVEYAHI SRLQADLNCL SDLLKSSIQW KYVINLCGQD FPLKSNFELV
241 SELKKLNGAN MLETVKPPNS KLERFTYHHE LRRVPYEYVK LPIRTNISKE APPHNIQIFV
301 GSAYFVLSQA FVKYIFNNSI VQDFFAWSKD TYSPDEHFWA TLIRVPGIPG EISRSAQDVS
361 DLQSKTRLVK WNYYEGFFYP SCTGSHLRSV CIYGAAELRW LIKDGHWFAN KFDSKVDPIL
421 IKCLAEKLEE QQRDWITLPS EKLFMDRNLT TTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCNT4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 23 nTPM
- small intestine: 19 nTPM
- stomach: 18 nTPM
- thymus: 14 nTPM
- parathyroid gland: 9 nTPM
- placenta: 6 nTPM
Single-cell type
- foveolar cells: 114 nCPM
- parietal cells: 78 nCPM
- cytotrophoblasts: 71 nCPM
- mucous neck cells: 66 nCPM
- mast cells: 49 nCPM
- endometrial luminal cells: 44 nCPM
Immune cell
- basophil: 23 nTPM
- T-reg: 18 nTPM
- memory CD4 T-cell: 11 nTPM
- naive CD4 T-cell: 11 nTPM
- naive CD8 T-cell: 8.2 nTPM
- MAIT T-cell: 5 nTPM
Brain region
- cerebral cortex: 8.7 nTPM
- basal ganglia: 5.4 nTPM
- white matter: 4.8 nTPM
- amygdala: 3.4 nTPM
- hippocampal formation: 2.7 nTPM
- medulla oblongata: 1.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.03
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- inter-male aggressive behavior
- kidney morphogenesis
- neutrophil homeostasis
- protein O-linked glycosylation
- protein O-linked glycosylation via N-acetyl-galactosamine
- thyroid hormone metabolic process
- tissue morphogenesis
Molecular functions
- acetylglucosaminyltransferase activity
- beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity
- N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCNT4 as an antibody target. Whether an autoantibody or antibody against GCNT4 could matter depends on whether native GCNT4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCNT4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GCNT4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...